Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): A randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial - Kadowaki, T; Isendahl, J; Khalid, U (Lancet Diabetes Endocrinol, 2022)